Complete Up To Date Information about Milbemite Otic Solution.
NADA Number: 141-163 | |
| Proprietary Name |
Milbemite Otic Solution |
|---|---|
| Sponsor |
Novartis Animal Health US, Inc. |
| Sponsor Address |
3200 Northline Ave, Suite 300 Greensboro, NC 27408 USA |
| Ingredients |
Milbemycin Oxime |
| Species |
Cat and kitten, excluding under 4 weeks of age |
| Routes of Administration |
Topical |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
4547520 |
| Exclusivity |
Granted for the treatment of ear mite infestations in cats and kittens eight weeks of age and older. Granted for the treatment of ear mite infestations in cats and kittens four weeks of age and older and to allow repeat treatment. |
|
Dosage Amount, Indications & Limitations |
524.1446 Milbemycin oxime solution. Specifications: Each tube contains 0.25 milliliter of a 0.1 percent solution of milbemycin oxime. Conditions of use: Cats and kittens One tube administered topically into each external ear canal. Indications: For the treatment of ear mite (Otodectes cynotis) infestations in cats and kittens 4 weeks of age and older. Effectiveness is maintained throughout the life cycle of the ear mite. Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |